← FDA DRUG APPROVALS

FDA ANDA · ANDA074568

CIMETIDINE

Sponsor: PLIVA

APPLICATION
ANDA074568
TYPE
ANDA
ORIGINAL APPROVAL
1997-02-27
LATEST ACTION
2005-03-03
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CIMETIDINEDiscontinued
CIMETIDINE 300MG · TABLET · ORAL
CIMETIDINEDiscontinued
CIMETIDINE 400MG · TABLET · ORAL
CIMETIDINEDiscontinued
CIMETIDINE 200MG · TABLET · ORAL

Approval history

2005-03-03Labeling · Supplement 9AP
2000-07-07Manufacturing (CMC) · Supplement 3AP
2000-05-10Manufacturing (CMC) · Supplement 2AP
1998-02-17Manufacturing (CMC) · Supplement 1AP
1997-02-27OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →